Results 161 to 170 of about 112,477 (323)

Patient decision-making in symptomatic gallbladder disease. [PDF]

Surg Endosc, 2022
Lois A, Droullard D, Lee J, Flum D.
europepmc   +1 more source

Gallbladder disease in patients with primary sclerosing cholangitis

, 2008
Genaro Vázquez‐Elizondo, Jimena Muciño-Bermejo, Nahúm Méndez‐Sánchez   +2 more
openalex   +1 more source

Ultrasonic Gallbladder Function in Chronic Kidney Disease: Does Predialysis, Hemodialysis, or CAPD Affect it? [PDF]

, 2005
Ahmet Bektaş, Ümit Belet, Engin Kelkitli, Tülay Bakir, Abdullah Serdar Açıkgöz, Tekin Akpolat   +5 more
openalex   +1 more source

Metabolic Syndrome and Obesity‐related cancer Risk and Survival: An Umbrella Review of Systematic Reviews With Meta‐analysis of Observational Studies

Obesity Reviews, EarlyView.
ABSTRACT Introduction Metabolic syndrome (MetS) may be associated with obesity‐related cancer (ORC) owing to shared risk factors like physical inactivity, insulin resistance, gut microbiome dysfunction, and inflammation. We conducted an umbrella review of systematic reviews with meta‐analysis to synthesize the evidence on the association between MetS ...
Maci Winn, Prasoona Karra, Ryzen Benson, Svenja Pauleck, Nathorn Chaiyakunapruk, Win Khaing, Sajesh K. Veettil, Mary M. McFarland, Tallie Casucci, Yizhe Xu, Siwen Hu‐Lieskovan, Michelle Litchman, Mary Playdon, Sheetal Hardikar   +13 more
wiley   +1 more source

Gallbladder disease is associated with the risk of cardiovascular disease among Uyghurs in Xinjiang: a prospective cohort study. [PDF]

BMC Public Health, 2023
Bai R, Wang J, Yang J, Cheng X, Zhang S, Zhang H, Wu X, Ma R, Zhang X, Guo H, Peng X, Guo S.   +11 more
europepmc   +1 more source

Nutrition Strategies for Next‐Generation Incretin Therapies: A Systematic Scoping Review of the Current Evidence

Obesity Reviews, EarlyView.
ABSTRACT Next‐generation incretin therapies, including semaglutide and tirzepatide, have transformed obesity and Type 2 diabetes management. However, evidence‐based nutritional strategies to support safe and effective use of these agents remain limited.
Marie Spreckley, Cara F. Ruggiero, Adrian Brown   +2 more
wiley   +1 more source

The safety of telemedicine clinics as an alternative to in-person preoperative assessment for elective laparoscopic cholecystectomy in patients with benign gallbladder disease: a retrospective cohort study. [PDF]

Patient Saf Surg, 2023
Urbonas T, Lakha AS, King E, Pepes S, Ceresa C, Udupa V, Soonawalla Z, Silva MA, Gordon-Weeks A, Reddy S.   +9 more
europepmc   +1 more source

Fluorine‐18 Fluorodeoxyglucose‐Positron Emission Tomography/Computed Tomography for Detection of Lymph Node Metastasis in Canine Mast Cell Tumour

Veterinary and Comparative Oncology, EarlyView.
ABSTRACT Lymph node (LN) metastasis has been associated with shorter survival times in dogs with mast cell tumour (MCT), and treatment of metastatic LN with lymphadenectomy or irradiation has been demonstrated to improve outcomes. Identification of metastatic LN in dogs with MCT is therefore of both prognostic and therapeutic significance.
Alison C. Williams, Monique N. Mayer, Ryan M. Dickinson, Sally L. Sukut, Valerie S. MacDonald‐Dickinson, Jerome Gagnon   +5 more
wiley   +1 more source

Benign gallbladder disease is a risk factor for colorectal cancer, but cholecystectomy is not: A propensity score matching analysis. [PDF]

Front Oncol, 2022
Qin Q, Li W, Ren A, Luo R, Luo S.
europepmc   +1 more source

If treating obesity with GLP‐1‐based therapies protects the heart, could it also prevent cancer or improve cancer outcomes? The case for randomized trials

Diabetes, Obesity and Metabolism, EarlyView.
Anastasios Tentolouris, Ioannis Ntanasis‐Stathopoulos   +1 more
wiley   +1 more source